Valuation : BioNote, Inc.

Market Cap 480B 358M 309M 292M 265M 497M 34.23B 500M 3.47B 1.34B 17.42B 1.35B 1.32B 55.04B P/E 2024
8.69x
P/E 2025 -6.32x
Enterprise Value 144B 108M 92.68M 87.75M 79.54M 149M 10.28B 150M 1.04B 401M 5.23B 404M 395M 16.52B EV / Sales 2024
0.77x
EV / Sales 2025 1.84x
Free-Float
12.48%
Yield 2024
4.25%
Yield 2025 -
1 day-0.10%
1 week-0.63%
Current month-0.21%
1 month-4.23%
3 months-1.04%
6 months-12.01%
Current year-12.98%
1 week 4,655
Extreme 4655
4,790
1 month 4,655
Extreme 4655
5,070
Current year 4,050
Extreme 4050
6,260
1 year 4,050
Extreme 4050
6,300
3 years 3,800
Extreme 3800
6,400
5 years 3,800
Extreme 3800
11,700
10 years 3,800
Extreme 3800
11,700
Manager TitleAgeSince
Chief Executive Officer 58 31/07/2020
Director of Finance/CFO 54 31/03/2021
Sales & Marketing 39 25/03/2025
Director TitleAgeSince
Chairman 65 28/02/2023
Director/Board Member 58 31/07/2020
Director/Board Member 50 -
Date Insider Type Main position Quantity % Market Cap. Importance
05/02/25 Free 10,000,000 9.8058%
05/02/25 Don

Chairman

10,000,000 9.8058%
14/04/24 Others 6,729,843 6.5991%
Change 5-day change 1-year change 3-year change Capi.($)
-0.10%-0.63%-21.19%-9.16% 358M
-0.34%-9.11%+14.18%-82.73% 2.16B
-0.69%-6.54%-54.21%-64.90% 1.41B
+0.23%-2.63%-48.73% - 52.97M
Average -0.22%-4.51%-27.49%-52.26% 994.23M
Weighted average by Cap. -0.43%-7.32%-14.01%-69.62%

Financials

2024 2025
Net sales 103B 76.68M 66.06M 62.55M 56.7M 106M 7.33B 107M 743M 286M 3.73B 288M 282M 11.78B 118B 88.27M 76.05M 72.01M 65.27M 122M 8.43B 123M 855M 329M 4.29B 332M 324M 13.56B
Net income 55.26B 41.23M 35.52M 33.63M 30.48M 57.19M 3.94B 57.48M 399M 154M 2B 155M 151M 6.33B -87.5B -65.28M -56.24M -53.25M -48.27M -90.55M -6.24B -91.01M -632M -243M -3.17B -245M -240M -10.03B
Net Debt -401B -300M -258M -244M -221M -416M -28.61B -418M -2.9B -1.12B -14.56B -1.12B -1.1B -46B -336B -251M -216M -205M -185M -348M -23.96B -350M -2.43B -934M -12.19B -942M -921M -38.52B
Logo BioNote, Inc.
BioNote Inc is a Korea-based company principally engaged in the bio-contents business. The Company is engaged in the manufacture and sale of rapid diagnostic kits for humans, diagnosis raw materials such as antigens, antibody cell lines, standards, enzymes and others as well as semi-finished products. The Company is also engaged in the manufacture and sale of rapid immunochemical diagnosis, enzyme immune rebound protein, immunochemical fluorescence diagnosis and other products used for animals.
Employees
299
Date Price Change Volume
11/09/26 ₩4,760.00 -0.10% 14,799
10/09/26 ₩4,765.00 +0.42% 43,391
09/09/26 ₩4,745.00 +1.39% 30,591
08/09/26 ₩4,680.00 -2.09% 45,688
07/09/26 ₩4,780.00 -0.21% 35,144
  1. Stock Market
  2. Stocks
  3. A377740 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!